SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 38.86

Change

+0.67 (+1.75)%

Market Cap

N/A

Volume

1.35M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

+5.83 (+1.45%)

USD 104.84B
REGN Regeneron Pharmaceuticals Inc

+14.04 (+1.96%)

USD 78.92B
ARGX argenx NV ADR

+3.25 (+0.50%)

USD 36.54B
ALNY Alnylam Pharmaceuticals Inc

+2.80 (+1.20%)

USD 30.22B
MRNA Moderna Inc

+4.96 (+11.65%)

USD 16.10B
UTHR United Therapeutics Corporatio..

+6.94 (+1.95%)

USD 15.91B
RPRX Royalty Pharma Plc

+0.29 (+1.13%)

USD 15.05B
SMMT Summit Therapeutics PLC

+0.69 (+3.95%)

USD 13.43B
INCY Incyte Corporation

+1.28 (+1.78%)

USD 13.41B
BMRN Biomarin Pharmaceutical Inc

+0.83 (+1.24%)

USD 12.74B

ETFs Containing SWTX

HFIN:CA Hamilton Enhanced Canadia.. 10.41 % 0.00 %

-0.05 (-0.26%)

CAD 0.19B
CDIV:CA Manulife Smart Dividend E.. 4.32 % 0.00 %

+0.03 (+-0.26%)

CAD 0.62B
HLIF:CA Harvest Canadian Equity I.. 3.45 % 0.00 %

-0.03 (-0.26%)

CAD 0.12B
CDEF:CA Manulife Smart Defensive .. 2.58 % 0.00 %

N/A

CAD 1.40M
CNCR Loncar Cancer Immunothera.. 1.68 % 0.79 %

+0.02 (+-0.26%)

USD 0.01B
CEW:CA iShares Equal Weight Banc.. 0.00 % 0.60 %

-0.06 (-0.26%)

CAD 0.24B
DXM:CA 0.00 % 0.67 %

N/A

N/A
FIE:CA iShares Canadian Financia.. 0.00 % 0.97 %

-0.02 (-0.26%)

CAD 1.09B
FLI:CA CI U.S. & Canada Lifeco C.. 0.00 % 0.92 %

-0.03 (-0.26%)

CAD 0.09B
HEF:CA 0.00 % 0.83 %

N/A

N/A
HPR:CA Global X Active Preferred.. 0.00 % 0.63 %

-0.01 (-0.26%)

CAD 1.04B
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

N/A

CAD 0.08B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

-0.08 (-0.26%)

N/A
TLV:CA Invesco S&P/TSX Composite.. 0.00 % 0.34 %

N/A

CAD 0.07B
XMD:CA iShares S&P/TSX Completio.. 0.00 % 0.61 %

-0.15 (-0.26%)

CAD 0.23B
XMV:CA iShares MSCI Canada Minim.. 0.00 % 0.33 %

-0.02 (-0.26%)

CAD 0.25B
BANK:CA Evolve Canadian Banks and.. 0.00 % 0.39 %

-0.03 (-0.26%)

CAD 0.33B
BNC:CA Purpose Canadian Financia.. 0.00 % 0.68 %

-0.02 (-0.26%)

N/A
TQCD:CA TD Q Canadian Dividend ET.. 0.00 % 0.00 %

-0.01 (-0.26%)

CAD 0.38B
TPIF Timothy Plan Internationa.. 0.00 % 0.00 %

-0.07 (-0.26%)

USD 0.11B
FICS First Trust International.. 0.00 % 0.00 %

-0.03 (-0.26%)

USD 0.16B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.56% 62% D 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.56% 62% D 77% C+
Trailing 12 Months  
Capital Gain -6.43% 62% D 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.43% 62% D 38% F
Trailing 5 Years  
Capital Gain 7.02% 77% C+ 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.02% 77% C+ 49% F
Average Annual (5 Year Horizon)  
Capital Gain 17.18% 63% D 70% C-
Dividend Return 17.18% 63% D 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 64.93% 54% F 30% F
Risk Adjusted Return 26.46% 81% B- 58% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector